Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Micaela Reddy

8PUBLICATIONS

72CO-AUTHORS

Molecular targetsPharmaceutical delivery technologiesFood properties (incl. characteristics and health benefits)Medical virology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Nov 11, 2025

An Evaluation of the Drug Interaction Potential of Encorafenib in Combination With Binimetinib Using the Inje Cocktail in Patients With Cancer.

Joseph Piscitelli, Micaela B Reddy, Lance Wollenberg

|Oct 18, 2024

Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective.

Micaela B Reddy, Tamara D Cabalu, Loeckie de Zwart

|May 01, 2024

A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation.

Rona Yaeger, Meredith A McKean, Rizwan Haq

|Oct 26, 2023

Oncology Combination Dose-Finding Study Design for Targeted and Immuno-Oncology Therapies.

Li Zhou, Micaela B Reddy, Rajendar K Mittapalli

|Oct 14, 2023

Impact of posaconazole and diltiazem on pharmacokinetics of encorafenib, a BRAF V600 kinase inhibitor for melanoma and colorectal cancer with BRAF mutations.

Erik Hahn, Renae Chavira, Lance Wollenberg

|Jun 03, 2023

SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.

Alexander Drilon, Manish R Sharma, Melissa L Johnson

Pageof 2

Frequent Collaborators

2 joint publications

John J Gaudino

2 joint publications

Lance Wollenberg

2 joint publications

Dylan P Hartley

2 joint publications

Anurag Singh

2 joint publications

S Michael Rothenberg

2 joint publications

Patrice A Lee

2 joint publications

Shirish M Gadgeel

2 joint publications

Wen-I Wu

2 joint publications

Gang Feng

2 joint publications

Eric N Brown

Frequent Collaborators

2 joint publications

John J Gaudino

2 joint publications

Lance Wollenberg

2 joint publications

Dylan P Hartley

2 joint publications

Anurag Singh

Top Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on : Jan 19, 2019

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Published on : Mar 28, 2017

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos

Top Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on : Jan 19, 2019

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Published on : Mar 28, 2017

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos